JP2009538910A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009538910A5 JP2009538910A5 JP2009513222A JP2009513222A JP2009538910A5 JP 2009538910 A5 JP2009538910 A5 JP 2009538910A5 JP 2009513222 A JP2009513222 A JP 2009513222A JP 2009513222 A JP2009513222 A JP 2009513222A JP 2009538910 A5 JP2009538910 A5 JP 2009538910A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- naphthylsulfonyl
- indazol
- optionally substituted
- alaninamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81001406P | 2006-06-01 | 2006-06-01 | |
| PCT/US2007/012570 WO2007142905A2 (en) | 2006-06-01 | 2007-05-25 | 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009538910A JP2009538910A (ja) | 2009-11-12 |
| JP2009538910A5 true JP2009538910A5 (cg-RX-API-DMAC7.html) | 2011-07-28 |
Family
ID=38656560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009513222A Withdrawn JP2009538910A (ja) | 2006-06-01 | 2007-05-25 | 5−ヒドロキシトリプタミン−6リガンドとしての1−スルホニルインダゾリルアミン誘導体および1−スルホニルインダゾリルアミド誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20070281922A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2029550A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009538910A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101432269A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007255042A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0712730A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2650082A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2008015329A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007142905A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6063870B2 (ja) * | 2010-11-08 | 2017-01-18 | ライセラ・コーポレイション | RORγ活性の阻害用のN−スルホニル化テトラヒドロキノリンおよび関連二環化合物および病気の治療 |
| EP2847198B1 (en) | 2012-05-08 | 2016-12-14 | Lycera Corporation | Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of ror-gamma and the treatment of disease |
| RU2014149136A (ru) | 2012-05-08 | 2016-07-10 | Мерк Шарп И Доум Корп. | ТЕТРАГИДРОНАФТИРИДИНОВЫЕ И РОДСТВЕННЫЕ БИЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ ДЛЯ ИНГИБИРОВАНИЯ RORγ АКТИВНОСТИ И ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ |
| WO2015095795A1 (en) | 2013-12-20 | 2015-06-25 | Merck Sharp & Dohme Corp. | TETRAHYDRONAPHTHYRIDINE, BENZOXAZINE, AZA-BENZOXAZINE, AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE |
| WO2015095788A1 (en) | 2013-12-20 | 2015-06-25 | Merck Sharp & Dohme Corp. | 2-ACYLAMIDOMETHYL AND SULFONYLAMIDOMETHYL BENZOXAZINE CARBAMATES FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE |
| WO2015095792A1 (en) | 2013-12-20 | 2015-06-25 | Merck Sharp & Dohme Corp. | Carbamate benzoxaxine propionic acids and acid derivatives for modulation of rorgamma activity and the treatment of disease |
| AU2015222917A1 (en) | 2014-02-27 | 2016-09-15 | Lycera Corporation | Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods |
| EP3140291A4 (en) | 2014-05-05 | 2018-01-10 | Lycera Corporation | Tetrahydroquinoline sulfonamide and related compounds for use as agonists of rory and the treatment of disease |
| WO2015171558A2 (en) | 2014-05-05 | 2015-11-12 | Lycera Corporation | BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE |
| US9550754B2 (en) | 2014-09-11 | 2017-01-24 | AbbVie Deutschland GmbH & Co. KG | 4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy |
| CA2975997A1 (en) | 2015-02-11 | 2016-08-18 | Merck Sharp & Dohme Corp. | Substituted pyrazole compounds as rorgammat inhibitors and uses thereof |
| WO2016179343A1 (en) | 2015-05-05 | 2016-11-10 | Lycera Corporation | DIHYDRO-2H-BENZO[b][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE |
| CN107980042B (zh) | 2015-06-11 | 2021-10-08 | 莱斯拉公司 | 用作RORγ激动剂和用于治疗疾病的芳基二氢-2H-苯并[b][1,4]噁嗪磺酰胺和相关化合物 |
| EP3368516B1 (en) | 2015-10-27 | 2020-07-15 | Merck Sharp & Dohme Corp. | SUBSTITUTED BICYCLIC PYRAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF |
| US10287272B2 (en) | 2015-10-27 | 2019-05-14 | Merck Sharp & Dohme Corp. | Substituted indazole compounds as RORgammaT inhibitors and uses thereof |
| JP2018531958A (ja) | 2015-10-27 | 2018-11-01 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | RORγT阻害薬としてのヘテロアリール置換安息香酸及びその使用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3539573A (en) * | 1967-03-22 | 1970-11-10 | Jean Schmutz | 11-basic substituted dibenzodiazepines and dibenzothiazepines |
| TW593278B (en) * | 2001-01-23 | 2004-06-21 | Wyeth Corp | 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| PL366639A1 (en) * | 2001-04-20 | 2005-02-07 | Wyeth | Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| KR20030088508A (ko) * | 2001-04-20 | 2003-11-19 | 와이어쓰 | 5-하이드록시트립타민-6 리간드로서의헤테로사이클릴옥시-, -티옥시- 및 -아미노벤즈아졸 유도체 |
-
2007
- 2007-05-25 EP EP07795389A patent/EP2029550A2/en not_active Withdrawn
- 2007-05-25 MX MX2008015329A patent/MX2008015329A/es not_active Application Discontinuation
- 2007-05-25 JP JP2009513222A patent/JP2009538910A/ja not_active Withdrawn
- 2007-05-25 CA CA002650082A patent/CA2650082A1/en not_active Abandoned
- 2007-05-25 AU AU2007255042A patent/AU2007255042A1/en not_active Abandoned
- 2007-05-25 WO PCT/US2007/012570 patent/WO2007142905A2/en not_active Ceased
- 2007-05-25 CN CNA200780015679XA patent/CN101432269A/zh active Pending
- 2007-05-25 BR BRPI0712730-8A patent/BRPI0712730A2/pt not_active IP Right Cessation
- 2007-05-31 US US11/809,425 patent/US20070281922A1/en not_active Abandoned